Literature DB >> 21756754

[Predictors of Wingspan in-stent restenosis for the treatment of symptomatic intracranial arterial stenosis].

Min-min Ma1, Qin Yin, Ge-lin Xu, Ren-liang Zhang, Shuang-gen Zhu, Xin-ying Fan, Wu-sheng Zhu, Xin-feng Liu.   

Abstract

OBJECTIVE: To analyze the predictors of Wingspan in-stent restenosis (ISR) for the treatment of symptomatic intracranial arterial stenosis.
METHODS: Between January 2007 and November 2009, 42 patients with symptomatic intracranial arterial stenosis registered in Nanjing stroke registry program (NSRP) were treated with Wingspan stent system. Clinical and follow-up results were retrospectively analyzed. They were divided into the non-restenosis and restenosis groups according to their follow-up imaging data. ISR was defined as > 50% stenosis within 5 mm or adjacent to stent or an absolute luminal loss > 20%. The analysis of stepwise multivariate Cox regression was performed to evaluate the independent predictive factors.
RESULTS: ISR was found in 15 patients (15/42, 35.7%) with 16 lesions (16/43, 37.2%) at a median follow-up period of 7 months (range: 4 - 23). Diabetes (HR = 0.281; 95%CI = 0.088 - 0.898; P = 0.032) and stent diameter (HR = 0.213; 95%CI = 0.049 - 0.918; P = 0.038) were two independent predictors for ISR.
CONCLUSION: Diabetes and stent diameter may be two independent predictors for ISR after a treatment of Wingspan system.

Entities:  

Mesh:

Year:  2011        PMID: 21756754

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

Review 1.  Stenting in Intracranial Stenosis: Current Controversies and Future Directions.

Authors:  Arindam R Chatterjee; Colin P Derdeyn
Journal:  Curr Atheroscler Rep       Date:  2015-08       Impact factor: 5.113

2.  Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).

Authors:  Colin P Derdeyn; David Fiorella; Michael J Lynn; Tanya N Turan; George A Cotsonis; Bethany F Lane; Jean Montgomery; L Scott Janis; Marc I Chimowitz
Journal:  Stroke       Date:  2017-04-28       Impact factor: 7.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.